Paul R. Edick

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

XERS

Current role

CEO, Board Member

2021-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Xeris Biopharma Holdings, Inc. (XERS)	Chief Executive Officer	$693,934	—	$930,000	—	$499,632	$13,200	$2,136,766
2022	Xeris Biopharma Holdings, Inc. (XERS)	Chief Executive Officer	$691,710	—	$1,686,000	—	$416,360	$11,529	$2,805,599
2021	Xeris Biopharma Holdings, Inc. (XERS)	Chief Executive Officer	$664,096	—	$1,143,000	$1,352,720	$598,518	$5,800	$3,764,134

No earnings-call appearances or filed executive changes recorded yet.